NOODLES & CO (NDLS)

US65540B1052 - Common Stock

1.19  +0.01 (+0.85%)

After market: 1.19 0 (0%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to NDLS. NDLS was compared to 135 industry peers in the Hotels, Restaurants & Leisure industry. Both the profitability and financial health of NDLS have multiple concerns. NDLS is valued expensive and it does not seem to be growing.



2

1. Profitability

1.1 Basic Checks

NDLS had negative earnings in the past year.
NDLS had a positive operating cash flow in the past year.
In multiple years NDLS reported negative net income over the last 5 years.
NDLS had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

The Return On Assets of NDLS (-2.67%) is worse than 73.88% of its industry peers.
NDLS has a worse Return On Equity (-36.22%) than 65.67% of its industry peers.
The Return On Invested Capital of NDLS (0.88%) is worse than 75.37% of its industry peers.
The Average Return On Invested Capital over the past 3 years for NDLS is significantly below the industry average of 10.32%.
Industry RankSector Rank
ROA -2.67%
ROE -36.22%
ROIC 0.88%
ROA(3y)-0.85%
ROA(5y)-1.74%
ROE(3y)-11.68%
ROE(5y)-22.07%
ROIC(3y)1.95%
ROIC(5y)N/A

1.3 Margins

NDLS's Operating Margin of 0.66% is on the low side compared to the rest of the industry. NDLS is outperformed by 76.12% of its industry peers.
In the last couple of years the Operating Margin of NDLS has declined.
NDLS's Gross Margin of 25.84% is on the low side compared to the rest of the industry. NDLS is outperformed by 82.84% of its industry peers.
NDLS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 0.66%
PM (TTM) N/A
GM 25.84%
OM growth 3YN/A
OM growth 5Y-15.7%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.17%
GM growth 5Y-0.51%

1

2. Health

2.1 Basic Checks

NDLS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for NDLS has been reduced compared to 1 year ago.
The number of shares outstanding for NDLS has been increased compared to 5 years ago.
Compared to 1 year ago, NDLS has a worse debt to assets ratio.

2.2 Solvency

NDLS has an Altman-Z score of 0.78. This is a bad value and indicates that NDLS is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of NDLS (0.78) is worse than 68.66% of its industry peers.
A Debt/Equity ratio of 3.01 is on the high side and indicates that NDLS has dependencies on debt financing.
NDLS has a Debt to Equity ratio (3.01) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 3.01
Debt/FCF N/A
Altman-Z 0.78
ROIC/WACC0.11
WACC8.29%

2.3 Liquidity

A Current Ratio of 0.34 indicates that NDLS may have some problems paying its short term obligations.
The Current ratio of NDLS (0.34) is worse than 92.54% of its industry peers.
NDLS has a Quick Ratio of 0.34. This is a bad value and indicates that NDLS is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of NDLS (0.18) is worse than 97.76% of its industry peers.
Industry RankSector Rank
Current Ratio 0.34
Quick Ratio 0.18

2

3. Growth

3.1 Past

The earnings per share for NDLS have decreased strongly by -900.00% in the last year.
The Revenue has decreased by -1.19% in the past year.
NDLS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.92% yearly.
EPS 1Y (TTM)-900%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-333.33%
Revenue 1Y (TTM)-1.19%
Revenue growth 3Y8.54%
Revenue growth 5Y1.92%
Revenue growth Q2Q-8.92%

3.2 Future

Based on estimates for the next years, NDLS will show a very negative growth in Earnings Per Share. The EPS will decrease by -52.05% on average per year.
NDLS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.54% yearly.
EPS Next Y-202.6%
EPS Next 2Y-52.05%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3%
Revenue Next 2Y3.54%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NDLS. In the last year negative earnings were reported.
Also next year NDLS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, NDLS is valued cheaply inside the industry as 91.79% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.45

4.3 Compensation for Growth

A cheap valuation may be justified as NDLS's earnings are expected to decrease with -52.05% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-52.05%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

NDLS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

NOODLES & CO

NASDAQ:NDLS (4/19/2024, 7:06:13 PM)

After market: 1.19 0 (0%)

1.19

+0.01 (+0.85%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap53.54M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.67%
ROE -36.22%
ROCE
ROIC
ROICexc
ROICexgc
OM 0.66%
PM (TTM) N/A
GM 25.84%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.37
Health
Industry RankSector Rank
Debt/Equity 3.01
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.34
Quick Ratio 0.18
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-900%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-202.6%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-1.19%
Revenue growth 3Y8.54%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y